• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHS2401380 瑞格列奈片 repaglinide Tablet Chemical Drugs(4) Generic Drug 2024-05-09 Chengdu Hengrui Pharmaceutical Co Ltd view
CYHS2302990 瑞格列奈片 repaglinide Tablet Chemical Drugs(4) Generic Drug 2023-11-03 Guangdong Pidi Pharmaceutical Co Ltd view
CYHS2302442 瑞格列奈片 repaglinide Tablet Chemical Drugs(4) Generic Drug 2023-09-11 Tonghua Wantong Pharmaceutical STOCK Co Ltd view
CYHS2201243 瑞格列奈片 repaglinide Tablet Chemical Drugs(4) Generic Drug 2022-08-05 Zhejiang Hisoar Pharmaceutical Co Ltd view
CYHB2250454 瑞格列奈片 repaglinide Tablet Chemical Drugs Supplementary Application 2022-07-21 Beijing Beilu Pharmaceutical Co Ltd view
JYHZ2100647 瑞格列奈片 repaglinide Tablet Chemical Drugs License Renew 2021-10-12 view
JYHZ2100648 瑞格列奈片 repaglinide Tablet Chemical Drugs License Renew 2021-10-12 view
CYHS2101284 瑞格列奈片 repaglinide Tablet Chemical Drugs(4) Generic Drug 2021-06-11 Tonghua Dongbao Pharmaceutical Co Ltd view
CYHB2101115 瑞格列奈片 repaglinide Tablet Chemical Drugs Supplementary Application 2021-04-14 Beijing Foyou Pharma Co Ltd view
CYHB2101117 瑞格列奈片 repaglinide Tablet Chemical Drugs Supplementary Application 2021-04-14 Beijing Foyou Pharma Co Ltd view
JYHB2002633 瑞格列奈片 repaglinide Tablet Chemical Drugs Supplementary Application 2020-12-21 诺和诺德(中国)制药有限公司 Novo Nordisk (China) Pharmaceuticals Co Ltd Filed 2021-01-06 view
JYHB2002634 瑞格列奈片 repaglinide Tablet Chemical Drugs Supplementary Application 2020-12-21 诺和诺德(中国)制药有限公司 Novo Nordisk (China) Pharmaceuticals Co Ltd Filed 2021-01-06 view
CYHB2009980 瑞格列奈片 repaglinide Tablet Chemical Drugs Supplementary Application 2020-12-03 北京北陆药业股份有限公司 Beijing Beilu Pharmaceutical Co Ltd In Review 2022-01-27 view
JYHB2000595 瑞格列奈片 repaglinide Tablet Chemical Drugs Supplementary Application 2020-05-18 诺和诺德(中国)制药有限公司 Novo Nordisk (China) Pharmaceuticals Co Ltd Filed 2020-06-03 view
JYHB2000594 瑞格列奈片 repaglinide Tablet Chemical Drugs Supplementary Application 2020-05-18 诺和诺德(中国)制药有限公司 Novo Nordisk (China) Pharmaceuticals Co Ltd Filed 2020-06-03 view
CYHB1950967 瑞格列奈片 repaglinide Tablet Chemical Drugs Supplementary Application 2020-01-07 北京福元医药股份有限公司 Beijing Foyou Pharma Co Ltd Certificate Issued 2020-10-21 view
CYHB1950966 瑞格列奈片 repaglinide Tablet Chemical Drugs Supplementary Application 2020-01-07 北京福元医药股份有限公司 Beijing Foyou Pharma Co Ltd Certificate Issued 2020-10-21 view
CYHB1850062 瑞格列奈片 repaglinide Tablet Chemical Drugs Supplementary Application 2018-05-30 江苏豪森药业集团有限公司 Jiangsu Hansoh Pharmaceutical Group Co Ltd Certificate Issued 2018-12-21 view
JYHZ1700037 瑞格列奈片 repaglinide Tablet Chemical Drugs License Renew 2017-08-03 诺和诺德(中国)制药有限公司 Novo Nordisk (China) Pharmaceuticals Co Ltd Certificate Issued 2018-01-16 view
JYHZ1700036 瑞格列奈片 repaglinide Tablet Chemical Drugs License Renew 2017-08-03 诺和诺德(中国)制药有限公司 Novo Nordisk (China) Pharmaceuticals Co Ltd Certificate Issued 2018-01-16 view